References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:https://doi.org/10.3322/caac.21492
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34. doi:https://doi.org/10.3322/caac.21551
- Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, et al., European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 Update. Eur Urol. 2019;75:799–810. doi:https://doi.org/10.1016/j.eururo.2019.02.011
- Culp SH, Karam JA, Wood CG. Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era. Urol Oncol. 2014;32(5):561–568. doi:https://doi.org/10.1016/j.urolonc.2013.12.003
- Morgan TM, Tang D, Stratton KL, Barocas DA, Anderson CB, Gregg JR, Chang SS, Cookson MS, Herrell SD, Smith JA, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol. 2011;59(6):923–928. doi:https://doi.org/10.1016/j.eururo.2011.01.034
- Hu H, Yao X, Xie X, Wu X, Zheng C, et al. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. World J Urol. 2017;35:261–270. doi:https://doi.org/10.1007/s00345-016-1864-9
- Hu Q, Gou Y, Sun C, Ding W, Xu K, Gu B, Xia G, Ding Q. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis. Urol Oncol. 2014;32(1):50.e1-8–50.e8. doi:https://doi.org/10.1016/j.urolonc.2013.07.016
- Shim SR, Kim SJ, Kim SI, Cho DS. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis. World J Urol. 2017;35(5):771–780. doi:https://doi.org/10.1007/s00345-016-1940-1
- Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85:1001–1005.
- Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol. 2002;28(4):396–400. doi:https://doi.org/10.1053/ejso.2002.1257
- Yang Y, Gao P, Chen X, Song Y, Shi J, Zhao J, Sun J, Xu Y, Wang Z. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget. 2016;7(36):58543–58552. doi:https://doi.org/10.18632/oncotarget.10148
- Wang SH, Zhai ST, Lin H. Role of Prognostic Nutritional Index in patients with gastric cancer: a meta-analysis. Minerva Med. 2016;107:322–327.
- Peng D, He Z-S, Li X-S, Tang Q, Zhang L, Yang K-W, Yu X-T, Zhang C-J, Zhou L-Q. Prognostic value of inflammatory and nutritional scores in renal cell carcinoma after nephrectomy. Clin Genitourin Cancer. 2017;15(5):582–590. doi:https://doi.org/10.1016/j.clgc.2017.04.001
- Kwon W-A, Kim S, Kim SH, Joung JY, Seo HK, Lee KH, Chung J. Pretreatment prognostic nutritional index is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with targeted therapy. Clin Genitourin Cancer. 2017;15(1):100–111. doi:https://doi.org/10.1016/j.clgc.2016.07.025
- Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi:https://doi.org/10.1371/journal.pmed.1000097
- Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi:https://doi.org/10.1186/1745-6215-8-16
- Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi:https://doi.org/10.1136/bmj.327.7414.557
- Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463. doi:https://doi.org/10.1111/j.0006-341x.2000.00455.x
- Yasar HA, Bir Yucel K, Arslan C, Ucar G, Karakaya S, Bilgin B, Taban H, Kucukarda A, Erturk I, Hızal M, et al. The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. J Oncol Pharm Pract. 2020;26(5):1110–1116. 1078155219883004 doi:https://doi.org/10.1177/1078155219883004
- Zheng Y, Bao L, Wang W, Wang Q, Pan Y, Gao X. Prognostic impact of the Controlling Nutritional Status score following curative nephrectomy for patients with renal cell carcinoma. Medicine (Baltimore). 2018;97:e13409. doi:https://doi.org/10.1097/md.0000000000013409
- Alcaraz AAC, Quinones-Capistran CA, Rodrlguez-Alvarez JS, Rodrlguez-Covarrubias F. The role of prognostic nutritional index to predict oncological outcomes in patients with clinical stage three or lower kidney cancer. J Urol. 2018;199(4 Supplement 1):e457.
- Kang M, Chang CT, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM. Prognostic significance of pre- to postoperative dynamics of the prognostic nutritional index for patients with renal cell carcinoma who underwent radical nephrectomy. Ann Surg Oncol. 2017;24:4067–4075. doi:https://doi.org/10.1245/s10434-017-6065-2
- Cai W, Zhong H, Kong W, Dong B, Chen Y, Zhou L, Xue W, Huang Y, Zhang J, Huang J, et al. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy. Int Urol Nephrol. 2017;49(11):1955–1963. doi:https://doi.org/10.1007/s11255-017-1693-9
- Jeon HG, Choi DK, Sung HH, Jeong BC, Seo SI, Jeon SS, Choi H-Y, Lee HM. Preoperative Prognostic Nutritional Index is a significant predictor of survival in renal cell carcinoma patients undergoing nephrectomy. Ann Surg Oncol. 2016;23(1):321–327. doi:https://doi.org/10.1245/s10434-015-4614-0
- Broggi MS, Patil D, Baum Y, Nieh PT, Alemozaffar M, Pattaras JG, Ogan K, Master MA. Onodera’s Prognostic Nutritional Index as an independent prognostic factor in clear cell renal cell carcinoma. Urology. 2016;96:99–105. doi:https://doi.org/10.1016/j.urology.2016.05.064
- Ohno Y, Nakashima J, Ohori M, Satake N, Kashima T, Gondo T, Nakagami Y, Tachibana M. Clinical significance of nutritional prognostic index in patients with clear cell renal cell carcinoma. J Urol. 2015;1:e533.
- Lucca I, de Martino M, Hofbauer SL, Zamani N, Shariat SF, Klatte T. Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma. World J Urol. 2015;33(12):2045–2052. doi:https://doi.org/10.1007/s00345-015-1559-7
- Hofbauer SL, Pantuck AJ, de Martino M, Lucca I, Haitel A, Shariat SF, Belldegrun AS, Klatte T. The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. Urol Oncol. 2015;33(2):68.e1-7–68.e7. doi:https://doi.org/10.1016/j.urolonc.2014.08.005
- Khandia R, Munjal A. Interplay between inflammation and cancer. Adv Protein Chem Struct Biol. 2020;119:199–245. doi:https://doi.org/10.1016/bs.apcsb.2019.09.004
- Souza Cunha M, Wiegert EVM, Calixto-Lima L, Oliveira LC. Relationship of nutritional status and inflammation with survival in patients with advanced cancer in palliative care. Nutrition. 2018;51-52:98–103. doi:https://doi.org/10.1016/j.nut.2017.12.004
- Lis CG, Gupta D, Lammersfeld CA, Markman M, Vashi PG. Role of nutritional status in predicting quality of life outcomes in cancer–a systematic review of the epidemiological literature. Nutr J. 2012;11:27. doi:https://doi.org/10.1186/1475-2891-11-27
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:https://doi.org/10.1016/j.cell.2011.02.013
- Shigdar S, Li Y, Bhattacharya S, O’Connor M, Pu C, Lin J, Wang T, Xiang D, Kong L, Wei MQ. et al. Inflammation and cancer stem cells. Cancer Lett. 2014;345:271–278. doi:https://doi.org/10.1016/j.canlet.2013.07.031
- Saroha S, Uzzo RG, Plimack ER, Ruth K, Al-Saleem T. Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma. J Urol. 2013;189(2):454–461. doi:https://doi.org/10.1016/j.juro.2012.09.166
- Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69(13):5383–5391. doi:https://doi.org/10.1158/0008-5472.CAN-08-3845
- Choueiri TK, Fay AP, Gray KP, Callea M, Ho TH, Albiges L, Bellmunt J, Song J, Carvo I, Lampron M, et al. PD-L1 expression in nonclear-cell renal cell carcinoma. Ann Oncol. 2014;25(11):2178–2784. doi:https://doi.org/10.1093/annonc/mdu445
- Giraldo NA, Becht E, Vano Y, Petitprez F, Lacroix L, Validire P, Sanchez-Salas R, Ingels A, Oudard S, Moatti A., et al. Tumor-infiltrating and peripheral blood t-cell immunophenotypes predict early relapse in localized clear cell renal cell carcinoma. Clin Cancer Res. 2017;23:4416–4428. doi:https://doi.org/10.1158/1078-0432.Ccr-16-2848
- Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC, et al. Decreased skeletal muscle mass is associated with an increased risk of mortality after radical nephrectomy for localized renal cell cancer. J Urol. 2016;195(2):270–276. doi:https://doi.org/10.1016/j.juro.2015.08.072
- Stenman M, Laurell A, Lindskog M. Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma. Med Oncol. 2014;31(3):841. doi:https://doi.org/10.1007/s12032-014-0841-7
- Chen Z, Shao Y, Wang K, Cao W, Xiong Y, Wu R, Luo S, Xu X, He X. Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis. Onco Targets Ther. 2016;9:6701–6710. doi:https://doi.org/10.2147/ott.S108469
- Corcoran AT, Kaffenberger SD, Clark PE, Walton J, Handorf E, Piotrowski Z, Tomaszewski JJ, Ginzburg S, Mehrazin R, Plimack E, et al. Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy. BJU Int. 2015;116(3):351–357. doi:https://doi.org/10.1111/bju.12897
- Esper DH, Harb WA. The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract. 2005;20:369–376. doi:https://doi.org/10.1177/0115426505020004369